Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.

Literature DB >> 12471212

Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.

D G R Evans, J M Birch, M Thorneycroft, G McGown, F Lalloo, J M Varley.

Abstract

Entities: Disease Gene

Mesh：

Year: 2002 PMID： 12471212 PMCID： PMC1757215 DOI： 10.1136/jmg.39.12.941

Source DB: PubMed Journal: J Med Genet ISSN： 0022-2593 Impact factor: 6.318

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Authors: Judy Mouchawar; Christopher Korch; Tim Byers; Todd M Pitts; Efang Li; Margaret R E McCredie; Graham G Giles; John L Hopper; Melissa C Southey
Journal: Cancer Res Date: 2010-05-25 Impact factor: 12.701

2. Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Authors: Christopher E Aston; David A Ralph; Dominique P Lalo; Sharmila Manjeshwar; Bobby A Gramling; Daniele C DeFreese; Amy D West; Dannielle E Branam; Linda F Thompson; Melissa A Craft; Debra S Mitchell; Craig D Shimasaki; John J Mulvihill; Eldon R Jupe
Journal: Hum Genet Date: 2004-12-21 Impact factor: 4.132

3. Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients.

Authors: Muhammad U Rashid; Sidra Gull; Kashif Asghar; Noor Muhammad; Asim Amin; Ute Hamann
Journal: Fam Cancer Date: 2012-06 Impact factor: 2.375

4. p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression.

Authors: Sachiyo Okayama; Levy Kopelovich; Gabriel Balmus; Robert S Weiss; Brittney-Shea Herbert; Andrew J Dannenberg; Kotha Subbaramaiah
Journal: J Biol Chem Date: 2014-01-22 Impact factor: 5.157

5. Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.

Authors: Paola Monti; Chiara Perfumo; Alessandra Bisio; Yari Ciribilli; Paola Menichini; Debora Russo; David M Umbach; Michael A Resnick; Alberto Inga; Gilberto Fronza
Journal: Mol Cancer Res Date: 2011-02-22 Impact factor: 5.852

Review 6. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors: R H Scott; C A Stiller; L Walker; N Rahman
Journal: J Med Genet Date: 2006-05-11 Impact factor: 6.318

Review 7. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors: April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal: Mol Diagn Ther Date: 2013-02 Impact factor: 4.074